Local and systemic innate immune response to secondary human peritonitis

Florence Riché(Zero to Three), Bernard Cholley(Assistance Publique – Hôpitaux de Paris), Didier Payen(Délégation Paris 7), Étienne Gayat(Inserm), Jean‐Marie Launay(Université Claude Bernard Lyon 1), Joaquim Matéo(Délégation Paris 5), Marie-Josèphe Laisné(Assistance Publique – Hôpitaux de Paris), Patrice Valleur(Hôpital Lariboisière), Corinne Collet(Northwestern University)

Critical Care

September 12, 2013

10.1186/cc12895

Cited by 37

Related Papers

Sepsis in European intensive care units: Results of the SOAP study*

|Critical Care Medicine|2006|2.9k

Safety, tolerability and efficacy of up-titration of guideline-directed medical therapies for acute heart failure (STRONG-HF): a multinational, open-label, randomised, trial

|The Lancet|2022|1k

A positive fluid balance is associated with a worse outcome in patients with acute renal failure

|Critical Care|2008|954

Sequential-Design, Multicenter, Randomized, Controlled Trial of Early Decompressive Craniectomy in Malignant Middle Cerebral Artery Infarction (DECIMAL Trial)

|Stroke|2007|867

Amoxicillin plus clavulanic acid versus appendicectomy for treatment of acute uncomplicated appendicitis: an open-label, non-inferiority, randomised controlled trial

|The Lancet|2011|674